603370 N华新精科
2025/06 - 中期2024/122023/122022/122017/12

盈利能力分析
净资产收益率 ROE (%)9.01915.91719.37531.39418.047
总资产报酬率 ROA (%)5.1979.20211.04717.10312.988
投入资产回报率 ROIC (%)6.10010.63212.73619.84013.668

边际利润分析
销售毛利率 (%)21.38120.43021.86316.89222.767
营业利润率 (%)14.53411.99315.01110.82811.288
息税前利润/营业总收入 (%)13.70611.74914.77110.46611.958
净利润/营业总收入 (%)12.69410.53513.1079.5419.704

收益指标分析
经营活动净收益/利润总额(%)100.601109.35297.096101.02699.700
价值变动净收益/利润总额(%)-0.2761.326-0.0810.0000.042
营业外收支净额/利润总额(%)0.114-0.221-0.637-0.6940.380

偿债能力分析
流动比率 (X)1.6141.5981.8201.6892.419
速动比率 (X)1.2761.2571.4881.4291.815
资产负债率 (%)38.92740.55340.71545.52131.334
带息债务/全部投入资本 (%)28.45931.67728.73233.97728.788
股东权益/带息债务 (%)243.750207.817236.587186.001247.005
股东权益/负债合计 (%)150.459139.628145.611119.677219.146
利息保障倍数 (X)-16.235-54.065-102.155-36.40619.091

营运能力分析
应收账款周转天数 (天)126.755106.609112.964136.63982.946
存货周转天数 (天)73.75967.56864.58354.19167.502